Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 8366113)

Published in J Biol Chem on September 15, 1993

Authors

J Parkkinen1, E Raulo, J Merenmies, R Nolo, E O Kajander, M Baumann, H Rauvala

Author Affiliations

1: Department of Medical Chemistry, University of Helsinki, Finland.

Articles citing this

HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 6.23

The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol (2001) 3.43

The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res (2010) 2.19

Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev (2004) 1.87

HMGB1 in health and disease. Mol Aspects Med (2014) 1.67

Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia (2009) 1.66

High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther (2008) 1.65

High mobility group 1 protein is not stably associated with the chromosomes of somatic cells. J Cell Biol (1997) 1.60

High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut (1999) 1.52

Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models. Mol Med (2011) 1.27

Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting. Nat Rev Drug Discov (2009) 1.21

An endothelial growth factor involved in rat renal development. J Clin Invest (1998) 1.12

DAMPs from Cell Death to New Life. Front Immunol (2015) 1.11

Plasminogen receptors: the first quarter century. Semin Thromb Hemost (2013) 1.09

Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation. Biochem J (1996) 1.04

Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease. Biochem J (1995) 0.99

Borna disease virus phosphoprotein binds a neurite outgrowth factor, amphoterin/HMG-1. J Virol (2001) 0.96

Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis. Arthritis Res Ther (2007) 0.96

Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC). Clin Exp Immunol (1998) 0.91

Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain. Brain Behav Immun (2014) 0.89

New insights into the role of Plg-RKT in macrophage recruitment. Int Rev Cell Mol Biol (2014) 0.89

High mobility group box-1 (HMGB1; amphoterin) is required for zebrafish brain development. J Biol Chem (2011) 0.85

A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes. PLoS One (2008) 0.85

Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products. Biochem J (2002) 0.84

Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation. Biochem J (2001) 0.84

High mobility group box 1 protein induction by Mycobacterium bovis BCG. Mediators Inflamm (2007) 0.81

Impact of serum biomarkers and clinical factors on intensive care unit mortality and 6-month outcome in relatively healthy patients with severe pneumonia and acute respiratory distress syndrome. Dis Markers (2014) 0.79

Staphylococcal toxic shock syndrome toxin-1 induces the translocation and secretion of high mobility group-1 protein from both activated T cells and monocytes. Mediators Inflamm (2008) 0.79

Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis. Onco Targets Ther (2015) 0.77

Prediction of carbohydrate-binding proteins from sequences using support vector machines. Adv Bioinformatics (2010) 0.77

Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10. Oncotarget (2016) 0.75

High mobility group protein 1: A collaborator in nucleosome dynamics and estrogen-responsive gene expression. World J Biol Chem (2016) 0.75

HMGB4 is expressed by neuronal cells and affects the expression of genes involved in neural differentiation. Sci Rep (2016) 0.75

Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke. Biosci Rep (2017) 0.75

Articles by these authors

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (1997) 6.37

Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science (2000) 5.44

Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med (1998) 4.04

The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J (2000) 3.52

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem (1999) 3.12

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J (1998) 3.01

Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem (2000) 2.78

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J (1999) 2.09

Association of cortactin with dynamic actin in lamellipodia and on endosomal vesicles. J Cell Sci (2000) 2.04

The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87

The structural basis of the different affinities of two types of acidic N-glycosidic glycopeptides for concanavalin A--sepharose. FEBS Lett (1976) 1.84

Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase. FEBS Lett (1989) 1.82

Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest (1988) 1.82

Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav (2001) 1.81

A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J (2000) 1.79

Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun (1996) 1.73

Cooperative effects of bacterial mutations affecting lambda N gene expression. I. Isolation and characterization of a nusB mutant. Virology (1976) 1.70

Long-term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences. Genes Brain Behav (2005) 1.70

The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart (2003) 1.63

Nanobacteria: an infectious cause for kidney stone formation. Kidney Int (1999) 1.59

Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor. Mol Cell Biol (2001) 1.58

Expression and localization pattern of ABCA1 in diverse human placental primary cells and tissues. Placenta (2011) 1.54

Studies on cell adhesion and recognition. I. Extent and specificity of cell adhesion triggered by carbohydrate-reactive proteins (glycosidases and lectins) and by fibronectin. J Cell Biol (1981) 1.52

Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency. Proc Natl Acad Sci U S A (1992) 1.46

Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J Biol Chem (1998) 1.46

30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem (1991) 1.46

Localisation of ABCA1 in first trimester and term placental tissues. Placenta (2010) 1.42

In vitro and in vivo radiation sensitivity of glioblastoma multiforme: correction. Int J Radiat Oncol Biol Phys (1996) 1.42

Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart (2004) 1.42

Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia (2007) 1.41

Regulation of cell migration by amphoterin. J Cell Sci (2000) 1.41

Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell (2001) 1.40

[Recommendations on the therapy of bronchial carcinoma]. Pneumologie (2002) 1.39

Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness. Oncogene (2010) 1.38

[Long-term outcome after coronary emergency intervention]. Dtsch Med Wochenschr (2000) 1.38

Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J Biol Chem (1994) 1.38

The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes Commun (1998) 1.37

Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem (1991) 1.36

Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int (1990) 1.36

senseless repression of rough is required for R8 photoreceptor differentiation in the developing Drosophila eye. Neuron (2001) 1.35

Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem (1984) 1.35

Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha2, a functional neurturin receptor. Neuron (1999) 1.35

Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. EMBO J (1991) 1.33

Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEBS Lett (1990) 1.33

Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int (2000) 1.32

Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens. Genes Brain Behav (2004) 1.32

A new method for the assay of tissue. S-adenosylhomocysteine and S-adenosylmethione. Effect of pyridoxine deficiency on the metabolism of S-adenosylhomocysteine, S-adenosylmethionine and polyamines in rat liver. Biochem J (1976) 1.31

Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development (1995) 1.30

Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost (2000) 1.29

Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Lett (1993) 1.24

A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same specificity as its natural counterpart. Infect Immun (1992) 1.23

Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat (2001) 1.23

Studies on cell adhesion and recognition. II. The kinetics of cell adhesion and cell spreading on surfaces coated with carbohydrate-reactive proteins (glycosidases and lectins) and fibronectin. J Cell Biol (1981) 1.22

Molecular cloning of the 18-kDa growth-associated protein of developing brain. J Biol Chem (1990) 1.22

Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol (2000) 1.21

Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J Intern Med (2004) 1.20

Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes. Biochem J (1990) 1.19

Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol (2004) 1.19

The poly(glycosyl) chains of glycoproteins. Characterisation of a novel type of glycoprotein saccharides from human erythrocyte membrane. Eur J Biochem (1978) 1.18

Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins. Infect Immun (1988) 1.15

Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res (1992) 1.13

Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia. Urology (1988) 1.13

Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem (1996) 1.12

Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother (2002) 1.12

Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis. Biochem J (1996) 1.11

Structural similarity of the terminal carbohydrate sequences of glycoproteins and glycolipids. FEBS Lett (1979) 1.09

Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res (2004) 1.08

The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons. J Cell Biol (1988) 1.08

Predictive factors in radiotherapy for non-small cell lung cancer: present status. Lung Cancer (2001) 1.07

Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriae associated with neonatal septicaemia and meningitis. Thromb Haemost (1991) 1.05

Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first Multicentre Study in Germany. Alcohol Alcohol (2001) 1.05

Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J Cell Biol (1998) 1.05

High affinity binding and overlapping localization of neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta with tenascin-R, amphoterin, and the heparin-binding growth-associated molecule. J Biol Chem (1998) 1.05

Studies on cell adhesion and recognition. III. The occurrence of alpha-mannosidase at the fibroblast cell surface, and its possible role in cell recognition. J Cell Biol (1981) 1.04

Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta (1990) 1.04

Cardiovascular risk factors and hemorheology. Physical fitness, stress and obesity. Atherosclerosis (1986) 1.03

Heparin-binding growth-associated molecule contains two heparin-binding beta -sheet domains that are homologous to the thrombospondin type I repeat. J Biol Chem (2000) 1.03

Regulation of rat liver acute phase genes by interleukin-6 and production of hepatocyte stimulating factors by rat hepatoma cells. Ann N Y Acad Sci (1989) 1.03

Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1). Kidney Int (2006) 1.03

Effect of buffered formalin on amplification of DNA from paraffin wax embedded small biopsies using real-time PCR. J Clin Pathol (2004) 1.02

The role of heparin-binding growth-associated molecule (HB-GAM) in the postsynaptic induction in cultured muscle cells. J Neurosci (1995) 1.02

Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol (2011) 1.02

Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J Neurosci (1999) 1.01

Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Int J Radiat Oncol Biol Phys (2001) 1.01

Molecular comparison of the structural proteins encoding gene clusters of two related Lactobacillus delbrueckii bacteriophages. J Virol (1993) 1.01

Efferent targets of osseous CGRP-immunoreactive nerve fiber before and after bone destruction in adjuvant arthritic rat: an ultramorphological study on their terminal-target relations. J Bone Miner Res (1997) 1.00

Monomer-micelle transition of the ganglioside GM1 and the hydrolysis by Clostridium perfringens neuraminidase. Eur J Biochem (1979) 0.99

Human leucocyte aspartylglucosaminidase. Evidence for two different subunits in a more complex native structure. Biochem J (1991) 0.99

Accelerated radiation therapy in non-small cell lung cancer. Radiother Oncol (1999) 0.98

Intercellular adhesion molecule-5 induces dendritic outgrowth by homophilic adhesion. J Cell Biol (2000) 0.98

The effect of particle inhalation on macrophage number and phagocytic activity in the intrapulmonary conducting airways of hamsters. Am J Respir Cell Mol Biol (1994) 0.98

Introduction: HMGB1 in inflammation and innate immunity. J Intern Med (2011) 0.98